Creating knowledge about adverse drug reactions: A critical analysis of the Danish reporting system from 1968 to 2005

Aagaard, Lise; Soendergaard, Birthe; Andersen, Elin; Kampmann, Jens P.; Hansen, Ebba Holme

doi:10.1016/j.socscimed.2007.04.026

Cited by 18 publications

(20 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A small percentage of ADRs were classified as "definitive", which is in accordance with other reports and evidences the difficulty in determining the absolute relationship of a drug with an event (1,4,14). Failures in completing the on-line form were detected for some items that were not available for all cases.…”

Section: Discussionsupporting

confidence: 87%

“…ADRs have been shown to be an important worldwide cause of hospitalization and death every year and are among the top ten causes of death in the United States (2)(3)(4)(5). Besides compromising people's health, ADRs generate unexpected costs that affect the economy of health systems, which is why the early identification, prevention and resolution of ADRs are necessary (5)(6)(7).…”

mentioning

confidence: 99%

See 1 more Smart Citation

Reacciones adversas a medicamos en una población colombiana 2007-2013

Machado‐Alba¹,

Londoño-Builes²,

Echeverri-Cataño³

et al. 2015

biomedica

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 87%

mentioning

confidence: 99%

Reacciones adversas a medicamos en una población colombiana 2007-2013

Machado‐Alba¹,

Londoño-Builes²,

Echeverri-Cataño³

et al. 2015

biomedica

View full text Add to dashboard Cite

“…DKMA receives approximately 2,000 ADR reports annually [7], corresponding to a reporting rate of close to 400 ADR reports per million inhabitants.…”

Section: Received Adr Reportsmentioning

confidence: 99%

“…Since the middle of the 1960s, ADR reporting systems have continuously undergone changes [6], and international alliances across national borders have been established, such as the joint European Medicines Agency (EMEA) in 1995 [6]. Despite good intentions, the established surveillance systems have not been able to foresee and prevent serious new ADR cases, such as those that led to the withdrawal of Vioxx (rofecoxib) due to thromboembolic events in 2004 [7]. A previous analysis of the Danish ADR reporting system showed that it lacked the potential to capture relevant and available information about previously undetected ADRs [7].…”

Section: Introductionmentioning

confidence: 99%

“…Despite good intentions, the established surveillance systems have not been able to foresee and prevent serious new ADR cases, such as those that led to the withdrawal of Vioxx (rofecoxib) due to thromboembolic events in 2004 [7]. A previous analysis of the Danish ADR reporting system showed that it lacked the potential to capture relevant and available information about previously undetected ADRs [7]. Brief and early descriptions about spontaneous ADR reporting systems have been published, see, e.g.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Structures and processes in spontaneous ADR reporting systems: a comparative study of Australia and Denmark

2008

Self Cite

View full text Add to dashboard Cite

The two systems differ with regard to reporting requirements, report handling, resources being spent and information exchange with the environment. In Denmark, learning about ADRs primarily takes place in the safety divisions of the pharmaceutical companies and the authorities have no control over the knowledge creation process. In Australia, more learning and control of the knowledge is present than in Denmark.

show abstract

Current awareness: Pharmacoepidemiology and drug safety

2008

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 20 sections: 1 Reviews; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Teratogens/fetal exposure; 20 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract

Creating knowledge about adverse drug reactions: A critical analysis of the Danish reporting system from 1968 to 2005

Cited by 18 publications

References 18 publications

Reacciones adversas a medicamos en una población colombiana 2007-2013

Reacciones adversas a medicamos en una población colombiana 2007-2013

Structures and processes in spontaneous ADR reporting systems: a comparative study of Australia and Denmark

Current awareness: Pharmacoepidemiology and drug safety

Contact Info

Product

Resources

About